NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CubaseBio

CubaseBio

Private
StockholmHealthcare & Life Scienceshttps://www.cubasebio.com/

Last Round

Grant

Feb 17, 2026

Total Funding Raised

$2.37M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CubaseBio is a biotechnology company that develops tools for 3D spatial analysis at scale, designed to accelerate drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

3D spatial transcriptomicsDNA microscopyspatial biologyspatial omicsorganoid analysisgene expression mappingdrug discovery toolsvolumetric spatial biologylife science toolsin situ analysisbiotech equipmentbioinformatics softwareresearch kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CubaseBio Comparables

Compare CubaseBio with similar companies based on industry and business-model similarity.

CubaseBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stellaromics
80%
Resolve Biosciences
78%
10X Genomics
74%

CubaseBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2026
VC RoundFeb 17, 2026

CubaseBio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 17, 2026

    $4.6M round led by Nordic Science Investments and Voima Ventures.

  • Feb 17, 2026

    Secured $2.37M in grant funding from the European Innovation Council.

CubaseBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CubaseBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CubaseBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersStockholm
Year Founded2024
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.